<I>PRKAG2</I>-associated hypertrophic cardiomyopathy
Mutations in the PRKAG2 gene lead to hypertrophic cardiomyopathy in combination with Wolff—Parkinson—White syndrome. The cause of the development of heart damage is the deposition of glycogen in the myocardium and the conduction system of the heart with a violation of the metabolism of adenosine mon...
Main Author: | I. V. Leontyeva |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ltd. “The National Academy of Pediatric Science and Innovation”
2022-08-01
|
Series: | Rossijskij Vestnik Perinatologii i Pediatrii |
Subjects: | |
Online Access: | https://www.ped-perinatology.ru/jour/article/view/1661 |
Similar Items
-
Hypertrophic cardiomyopathy caused by mutations in the <I>PRKAG2</I> gene
by: I. V. Leontyeva, et al.
Published: (2022-09-01) -
Danon’s disease as a cause of hypertrophic cardiomyopathy
by: I. V. Leontyeva, et al.
Published: (2016-03-01) -
Mitral valve replacement or repair: choosing optimal surgical treatment of hypertrophic obstructive cardiomyopathy
by: Богачев-Прокофьев А. В., et al.
Published: (2016-01-01) -
Первый опыт расширенной миоэктомии при хирургическом лечении обструктивной гипертрофической кардиомиопатии: непосредственные и промежуточные результаты
by: А. В. Богачев-Прокофьев, et al.
Published: (2015-10-01) -
Medico-genetic counseling in primary arrhythmia prevention
by: I. G. Fomina, et al.
Published: (1970-01-01)